Cristiano Ronaldo, the Portuguese football icon, is making headlines off the field as well. The superstar has invested $7.5 million to acquire a 10 % stake in HBL Pro2col Software LLC, a health tech company owned by Herbalife. The company uses technology to provide personalised nutrition and wellness plans, combining health data with software to help users achieve better lifestyles.
The announcement immediately excited investors. Following news of Ronaldo’s investment, Herbalife’s shares surged more than 15 %, reflecting the market’s positive response. This boost comes alongside Herbalife’s recent financial results, which showed steady sales growth for 2025 and stronger performance in the fourth quarter, further cementing investor confidence.
Ronaldo has been associated with Herbalife for years as a brand ambassador, endorsing their products since 2013. However, this move marks his first publicly disclosed financial investment in the company. In a statement, Ronaldo described the deal as a “natural next step” in his long-standing relationship with Herbalife. He emphasized his personal commitment to health, wellness, and innovation, saying that the investment aligns with his passion for promoting healthier lifestyles.
For Herbalife, the investment is more than just a financial boost—it is also a significant endorsement from one of the world’s most influential athletes, highlighting the growing intersection between sports, wellness, and technology. The company’s platform, Pro2col, aims to revolutionize the way people approach nutrition and personal wellness, combining data-driven insights with tailored health plans.
Ronaldo’s involvement could attract more attention to the wellness technology sector, inspiring other high-profile investors to explore similar opportunities. For Ronaldo, this investment represents a blending of personal interest and strategic business acumen, demonstrating how athletes are increasingly leveraging their influence to make impactful business decisions.
Also Read: Mark Zuckerberg grilled in social media addiction trial